Arformoterol Tartrate Patent Expiration
Arformoterol Tartrate is Used for maintenance treatment of bronchoconstriction in patients with COPD. It was first introduced by Lupin Inc
Arformoterol Tartrate Patents
Given below is the list of patents protecting Arformoterol Tartrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Brovana | US6472563 | Formoterol tartrate process and polymorph |
Nov 09, 2021
(Expired) | Lupin |
| Brovana | US6720453 | Formoterol tartrate polymorph |
Nov 09, 2021
(Expired) | Lupin |
| Brovana | US7145036 | Formoterol tartrate polymorph |
Nov 09, 2021
(Expired) | Lupin |
| Brovana | US8110706 | Formoterol tartrate process and polymorph |
Nov 09, 2021
(Expired) | Lupin |
| Brovana | US6667344 | Bronchodilating compositions and methods |
Jun 22, 2021
(Expired) | Lupin |
| Brovana | US6814953 | Bronchodilating compositions and methods |
Jun 22, 2021
(Expired) | Lupin |
| Brovana | US7348362 | Bronchodilating β-agonist compositions and methods |
Jun 22, 2021
(Expired) | Lupin |
| Brovana | US7462645 | Bronchodilating beta-agonist compositions and methods |
Jun 22, 2021
(Expired) | Lupin |
| Brovana | US7465756 | Bronchodilating beta-agonist compositions and methods |
Jun 22, 2021
(Expired) | Lupin |
| Brovana | US7473710 | Bronchodilating beta-agonist compositions and methods |
Jun 22, 2021
(Expired) | Lupin |
| Brovana | US7541385 | Bronchodilating β-agonist compositions and methods |
Jun 22, 2021
(Expired) | Lupin |
| Brovana | US6040344 | Formoterol process |
Nov 12, 2016
(Expired) | Lupin |
| Brovana | US6589508 | Methods and compositions for treating pulmonary disorders using optically pure (R,R) formoterol |
Apr 03, 2013
(Expired) | Lupin |
Arformoterol Tartrate's Family Patents
Explore Our Curated Drug Screens
Arformoterol Tartrate Generic API Manufacturers
Several generic applications have been filed for Arformoterol Tartrate. The first generic version for Arformoterol Tartrate was by Be Pharmaceuticals Ag and was approved on Jun 22, 2021. And the latest generic version is by Dr Reddys Laboratories Ltd and was approved on Jun 3, 2024.
Given below is the list of companies who have filed for Arformoterol Tartrate generic, along with the locations of their manufacturing plants worldwide.
1. AIPING PHARM INC
Aiping Pharmaceutical Inc has filed for 1 generic for Arformoterol Tartrate. Given below are the details of the strengths of this generic introduced by Aiping Pharm Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.015MG BASE/2ML | solution | Prescription | INHALATION | AN | Apr 2, 2024 |
2. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Arformoterol Tartrate. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.015MG BASE/2ML | solution | Prescription | INHALATION | AN | May 10, 2022 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
3. BE PHARMS
Be Pharmaceuticals Ag has filed for 1 generic for Arformoterol Tartrate. Given below are the details of the strengths of this generic introduced by Be Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.015MG BASE/2ML | solution | Prescription | INHALATION | AN | Jun 22, 2021 |
4. CF PHARMTECH
Cf Pharmtech Inc has filed for 1 generic for Arformoterol Tartrate. Given below are the details of the strengths of this generic introduced by Cf Pharmtech.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.015MG BASE/2ML | solution | Prescription | INHALATION | AN | May 17, 2024 |
5. CIPLA
Cipla Ltd has filed for 1 generic for Arformoterol Tartrate. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.015MG BASE/2ML | solution | Prescription | INHALATION | AN | Jun 22, 2021 |
Manufacturing Plant Locations New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
6. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 1 generic for Arformoterol Tartrate. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.015MG BASE/2ML | solution | Prescription | INHALATION | AN | Jun 3, 2024 |
7. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 1 generic for Arformoterol Tartrate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.015MG BASE/2ML | solution | Discontinued | INHALATION | N/A | Jun 22, 2021 |
8. LUPIN
Lupin Inc has filed for 1 generic for Arformoterol Tartrate. Given below are the details of the strengths of this generic introduced by Lupin.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.015MG BASE/2ML | solution | Prescription | INHALATION | AN | Feb 7, 2022 |
Manufacturing Plant Locations New
Lupin's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Lupin as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||||||||||||||||
| United States |
| |||||||||||||||||||||||||||||
9. MANKIND PHARMA
Mankind Pharma Ltd has filed for 1 generic for Arformoterol Tartrate. Given below are the details of the strengths of this generic introduced by Mankind Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.015MG BASE/2ML | solution | Prescription | INHALATION | AN | Nov 15, 2022 |
Manufacturing Plant Locations New
Mankind Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Mankind Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
10. RITEDOSE CORP
The Ritedose Corp has filed for 1 generic for Arformoterol Tartrate. Given below are the details of the strengths of this generic introduced by Ritedose Corp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.015MG BASE/2ML | solution | Prescription | INHALATION | AN | Mar 2, 2022 |
11. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 1 generic for Arformoterol Tartrate. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.015MG BASE/2ML | solution | Prescription | INHALATION | AN | May 26, 2022 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||
12. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 1 generic for Arformoterol Tartrate. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.015MG BASE/2ML | solution | Prescription | INHALATION | AN | Nov 9, 2021 |
13. WILSHIRE PHARMS INC
Wilshire Pharmaceuticals Inc has filed for 1 generic for Arformoterol Tartrate. Given below are the details of the strengths of this generic introduced by Wilshire Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.015MG BASE/2ML | solution | Prescription | INHALATION | AN | Nov 25, 2022 |